Gilead Sciences Inc. (GILD) posted revenue of $7.42 billion beating estimates of by $922 million, with an EPS of $1.88.
We are glad you are enjoying our content and we’d like to help you achieving your financial goals.
This content is only for Rivkin Report Members.
Start a free 14-day trial to access this article and:
-
✓ 6 Model Portfolios for Income and Growth
-
✓ In-Depth Stock Analysis: identify potential investment opportunities
-
✓ Q&A sessions with our CIO, Shannon Rivkin